Quadrant Growth Fund 2 Invests in Evolution Surgical
August 26, 2024
Quadrant Private Equity, via its $530 million Growth Fund 2, has agreed to invest in Evolution Surgical, an Australian designer and manufacturer of spinal implants and biologics. The firm will partner with Evolution CEO Jack Lancaster and management to support the company’s product development and commercial expansion.
- Buyers
- Quadrant Private Equity (Growth Fund 2)
- Targets
- Evolution Surgical
- Industry
- Medical Devices
- Location
- New South Wales, Australia
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Precision Edge Surgical Products Acquires Eva-Lution
May 6, 2022
Medical Devices
Precision Edge Surgical Products Company has completed an asset acquisition of Angola, Indiana-based Eva-Lution to expand its orthopedic and medical instrument manufacturing capacity. The acquisition adds Eva-Lution's more than 60,000-square-foot facility and manufacturing equipment to Precision Edge's operations and is intended to accelerate implant manufacturing capabilities and better serve orthopedic OEM customers in Northeast Indiana.
-
Zero Two and Warburg Pincus take co-controlling stake in Evolution Data Centres
August 12, 2025
Infrastructure
Zero Two has made a strategic investment in Evolution Data Centres, assuming a co-controlling position alongside Warburg Pincus to provide long-term growth capital for the expansion of hyperscale-ready data centres across Southeast Asia. The partnership will accelerate Evolution's deployment in markets including Thailand, the Philippines, and Vietnam and advance its sustainability goals through renewable energy PPAs.
-
Quadrant Private Equity Backs Three New Zealand Cybersecurity Firms
March 30, 2023
Cybersecurity
Quadrant Private Equity’s $530 million second growth fund has invested in three New Zealand cybersecurity businesses — Quantum Security Services, ZX Security and Helix Security Services — which provide GRC, penetration testing, cloud security and cyber advisory services. The trio serves over 200 enterprise and government customers and has seen combined revenue grow more than 35% over the past three years; the firms have been brought together as part of a broader consolidation in the New Zealand cybersecurity market.
-
Baird Capital Invests $53M in EvoluteIQ
September 17, 2025
AI & Machine Learning
Baird Capital has made a $53 million growth investment in EvoluteIQ, an AI-native platform that automates end-to-end business processes. The funding will be used to accelerate EvoluteIQ's global expansion and scale its enterprise agentic AI capabilities across industries including banking, insurance, healthcare, telecom and manufacturing.
-
Revelstoke Capital Partners Makes Growth Investment in MediQuant
September 4, 2024
Healthcare Services
Revelstoke Capital Partners, a Denver-based healthcare private equity firm, announced a significant growth investment in MediQuant, a provider of cloud-based data archiving and interoperability solutions for hospitals and health systems. The investment (Revelstoke Fund III) will support expansion of MediQuant's DataArk platform and capabilities; terms were not disclosed.
-
BDC Growth Equity Leads $23M Growth Investment in Quadshift
February 19, 2025
Software
Quadshift raised up to $23 million of growth equity in an all-primary, all-equity round led by BDC Growth Equity Partners with participation from Celtic House Venture Partners and other minority investors. The funding will accelerate Quadshift's acquisitive strategy to buy vertically focused B2B software businesses and expand its platform capabilities using AI-enabled deal sourcing and shared operational resources.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.